Colonics
 
About Me

Colonics resources

Recent Posts
Menu
Calendar
«  July 2014  »
MonTueWedThuFriSatSun
 123456
78910111213
14151617181920
21222324252627
28293031 

Friends
    Links


    Entry 1 of 3073
    Last Page | Next Page
    3/17/2010 - Protalix BioTherapeutics commences clinical trial of human acetylcholinesterase for biodefense indications
    Posted in Medical News

    Protalix BioTherapeutics, Inc. announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell denote pegylated recombinant human acetylcholinesterase product petitioner in growth for biodefense indications. The trial is designed to study the safety of PRX-105 by administering a bolus intravenous injection of PRX-105 in healthy volunteers.

    More: - Read More

    Share |

    :: Send to a Friend!

    Share and enjoy
    • Digg
    • del.icio.us
    • DZone
    • Netvouz
    • NewsVine
    • Reddit
    • Slashdot
    • StumbleUpon
    • Technorati
    • YahooMyWeb
     
    portfolio